Milan Patel
United States Of America • 61 years
Investments
Investment
time of Investment
About Milan Patel
CEO and Co-Founder at PathogenDx Over twenty years of corporate & entrepreneurial experience having worked for small/mid-size businesess to Fortune 50 companies. My professional goal is to engage with small-to-medium sized companies and help them grow financially, organizationally, innovatively, and culturally to the next level.
Milan Patel Prominent Investment Areas
Business Support Services Clean-Tech Commerce and Shopping +8 more investments
Key Focus Areas of invested Startups by Milan Patel
Antiviral Reusable Mask Cosmetics Industries Demand Forecasting +14 more focus areasMilan Patel Recent Experience
CEO and Co-Founder
PathogenDx, United States of AmericaInvestor & C-Level Consultant
Genomics USA, Inc dba GMSBiotech, Inc., United States of AmericaCEO
PathogenDx, LLC, United States of AmericaMilan Patel Education (joining year)
PG
(1987)PG
(1986)UG
(1983)
Get Access to Complete Information
Signup NowYNOS is not associated with any of the entities (organisations / people) mentioned in this page. Information provided here has been curated from multiple public as well as proprietary sources. All efforts have been taken to make it accurate and complete. If details are insufficient or not accurate, kindly reach out to sales@ynos.in
Get more information with Incubators
The Ultimate Platform for Finding the Right Incubator and Accelerator.
Get more information with Debt Funding
Discover Top Loan & Debt Funding Schemes for Startups in India.
Get more information with Govt. Funding
Discover & analyse the best government funding avenues for your startup in India.
Get more information with Insight
The most powerful dashboard solution on Indian Startups & Investors.
Try StartupGPT, an AI-Assistant for Founders & Investors
Your conversational companion for Indian Startups, Funding, and much more.
- slide 1 of 8, currently active
- slide 2 of 8
- slide 3 of 8
- slide 4 of 8
- slide 5 of 8
- slide 6 of 8
- slide 7 of 8
- slide 8 of 8
